Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

NanoSight Announces the Launch of New NS300 System

Published: Wednesday, March 06, 2013
Last Updated: Wednesday, March 06, 2013
Bookmark and Share
New instrument provides a platform for enhanced fluorescence and rheological applications.

NanoSight reports on the new NS300 system based on their Nanoparticle Tracking Analysis technology.

The NS300 utilizes the latest version of NanoSight's particle characterization technology, Nanoparticle Tracking Analysis (NTA).

This elegant new instrument offers all the unique benefits scientists have come to expect from NanoSight in an easy to use and compact format.

The NS300 can visualize and measure particles in suspension in the size range 10-2000 nm (depending on material) and addresses the needs of a wide variety of applications including protein aggregation, exosome and microvesicle research, drug delivery systems, characterizes materials under the new EU Definition of Nanomaterials, and is particularly suited to analysis of particles labelled with fluorescent quantum dots.

This latest NanoSight instrument provides multi-faceted analysis that now includes spinning disc technology enabling simultaneous multi-fluorescent detection, as well as a rheology feature that can measure viscosity in the range 0-5 centipoise.

With a footprint measuring just 40 cm long by 25 cm wide, the NS300 is packed with NanoSight's latest developments. It comes complete with a high sensitivity CMOS camera, temperature control, a choice of laser block and can be upgraded to include the spinning disc.

It complements the NanoSight family of instruments by providing an answer to researchers whose laboratory space is at a premium without compromising on quality or functionality.

A new top plate and laser module block are removable to enable easy cleaning and assembly.

The top plate comes with a replaceable sample chamber designed with a special stem to enable removal without having to handle the sensitive sample area.

Patrick Hole, NanoSight's head of product development, says of the new instrument "The NS300 is the natural progression from the NS500 and LM10. It takes the most popular features of these instruments and combines them into an easy to use compact format. We then added in all the latest developments we have been working on including the high capacity motorized fluorescence disc. This unit, capable of being programmed from within the software to address up to six different fluorescent filters, will facilitate the more rapid assessment of fluorophores using the appropriate filters and gives users the possibility of being able to analyze each fluorescence population in terms of size and concentration."

NanoSight has installed more than 500 systems worldwide with users including BASF, GlaxoSmithKline, Merck, Novartis, Pfizer, Proctor and Gamble, Roche and Unilever together with the most eminent universities and research institutes.

NanoSight's technology is validated by 600+ third party papers citing results obtained using NTA.

NanoSight's leadership position in nanoparticle characterization is consolidated further with publication of an ASTM International standard, ASTM E2834, which describes the NTA methodology for detection and analysis of nanoparticles.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Method Development to Estimate the Purity of Vesicle Preparations
Nanoparticle tracking analysis is used to estimate the purity of vesicle preparations at the Cardiff University School of Medicine.
Thursday, February 28, 2013
NanoSight Announce New Appointment
Leading UK scientist, Dr Andrew Shuttleworth, joins NanoSight board as Director of Diagnostic Sciences.
Tuesday, June 26, 2012
Landmark Publication Reports Potential of Exosomes as Biomarkers for Early Disease Detection
NanoSight reports the new publication in one of the most cited peer reviewed journals in nanoscience and nanotechnology, NanoMedicine.
Thursday, July 07, 2011
NanoSight announces interactive webinar on January 27th on Exosome Characterization by Nanoparticle Tracking Analysis
NanoSight, world-leading manufacturers of unique nanoparticle characterization technology, will host an interactive webinar on the subject of exosome characterization by Nanoparticle Tracking Analysis.
Thursday, January 20, 2011
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos